SO
STRS Ohio Portfolio holdings
AUM
$26.8B
1-Year Return
24.25%
This Quarter Return
+23.23%
1 Year Return
+24.25%
3 Year Return
+105.97%
5 Year Return
+185.64%
10 Year Return
+428.63%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$3.11M
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
313
Increased
959
Reduced
613
Closed
175
Top Buys
| 1 |
Golub Capital BDC
GBDC
|
+$77.5M |
| 2 |
Keysight
KEYS
|
+$53.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$46.8M |
| 4 |
AbbVie
ABBV
|
+$43M |
| 5 |
Merck
MRK
|
+$40.1M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
TransDigm Group
TDG
|
+$50.5M |
| 3 |
Stryker
SYK
|
+$42.1M |
| 4 |
Johnson & Johnson
JNJ
|
+$41M |
| 5 |
Trane Technologies
TT
|
+$40.3M |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Voyager Therapeutics
VYGR
$232M
| $488K | ﹤0.01% |
38,700
-6,700
| -15% | -$84.5K |
|
1327
iRadimed
IRMD
$907M
| $487K | ﹤0.01% |
21,000
+900
| +4% | +$20.9K |
|
|
MNK
1328
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $487K | ﹤0.01% |
181,800
-51,500
| -22% | -$138K |
|
|
EVRI
1329
DELISTED
Everi Holdings
EVRI
| $486K | ﹤0.01% |
94,300
-64,500
| -41% | -$332K |
|
1330
Minerva Neurosciences
NERV
$15.2M
| $486K | ﹤0.01% |
+16,838
| New | +$486K |
|
1331
Ryerson Holding
RYI
$723M
| $484K | ﹤0.01% |
86,000
+13,100
| +18% | +$73.7K |
|
1332
Harvard Bioscience
HBIO
$19.7M
| $480K | ﹤0.01% |
+155,100
| New | +$480K |
|
1333
Univest Financial
UVSP
$886M
| $480K | ﹤0.01% |
29,800
+2,600
| +10% | +$41.9K |
|
|
SCWX
1334
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $480K | ﹤0.01% |
42,000
+2,800
| +7% | +$32K |
|
|
IHC
1335
DELISTED
Independence Holding Company
IHC
| $480K | ﹤0.01% |
15,700
+1,300
| +9% | +$39.7K |
|
1336
HarborOne Bancorp
HONE
$563M
| $479K | ﹤0.01% |
56,200
+4,600
| +9% | +$39.2K |
|
1337
Columbus McKinnon
CMCO
$415M
| $478K | ﹤0.01% |
14,300
+1,200
| +9% | +$40.1K |
|
|
UNIT
1338
Uniti Group
UNIT
$1.71B
| $478K | ﹤0.01% |
51,200
+1,800
| +4% | +$16.8K |
|
|
AT
1339
DELISTED
Atlantic Power Corporation
AT
| $477K | ﹤0.01% |
238,500
+19,700
| +9% | +$39.4K |
|
|
BSTC
1340
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $477K | ﹤0.01% |
7,800
+600
| +8% | +$36.7K |
|
1341
Midland States Bancorp
MSBI
$385M
| $476K | ﹤0.01% |
31,900
+7,700
| +32% | +$115K |
|
1342
NVE Corp
NVEC
$328M
| $476K | ﹤0.01% |
7,700
+600
| +8% | +$37.1K |
|
|
VIA
1343
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $476K | ﹤0.01% |
13,480
+500
| +4% | +$17.7K |
|
1344
Central Garden & Pet
CENT
$2.24B
| $475K | ﹤0.01% |
+16,500
| New | +$475K |
|
1345
Unisys
UIS
$282M
| $474K | ﹤0.01% |
43,500
+3,600
| +9% | +$39.2K |
|
1346
XBiotech
XBIT
$83.8M
| $472K | ﹤0.01% |
34,500
+13,007
| +61% | +$178K |
|
|
LAND
1347
Gladstone Land Corp
LAND
$321M
| $471K | ﹤0.01% |
29,753
+742
| +3% | +$11.7K |
|
1348
Scholar Rock
SRRK
$3.04B
| $471K | ﹤0.01% |
25,900
+2,100
| +9% | +$38.2K |
|
1349
Heidrick & Struggles
HSII
$1.03B
| $469K | ﹤0.01% |
21,700
+1,800
| +9% | +$38.9K |
|
1350
Utah Medical Products
UTMD
$200M
| $469K | ﹤0.01% |
5,300
| – | – |
|